Johnson, 27, was one of 600 people in 20 fields nationwide to be recognized as a leader in business and industry; only four percent of the 15,000 applicants were selected.
He is currently a PhD candidate at Rutgers University.
Visikol, founded by Johnson with partners Thomas Villani and Nick Crider, allows scientists to view tissue in 3D rather than the traditional 2D slide-based approach rendering tissues transparent -- adding significant value to fields like drug development and cancer diagnostics as it allows for more accurate information to be obtained from tissue.
The company recently launched Visikol® HISTO™, which requires no special equipment to clear tissue and provides a rapid, non-destructive, easy-to-use process that allows any researcher to add a new dimension to his or her research with the power of tissue clearing.
The technology is now being used by more than 160 researchers in the U.S. and Europe.
Visikol has raised $800,000 in venture capital and grants to advance its technology, including a $500,000 investment from Foundation Venture Capital Group, a $225,000 SBIR grant from the National Science Foundation and a recent $50,000 Innovation Corps Grant from the National Science Foundation.
"I'm incredibly honored to be recognized by Forbes for our accomplishments with Visikol. My co-founders and I look forward to moving our technology forward, improving clinical diagnostics," Johnson said.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/visikol-co-founder-michael-johnson-named-to-2017-forbes-30-under-30-list-300389378.html
|SOURCE Foundation Venture Capital Group, LLC|
Copyright©2017 PR Newswire.
All rights reserved
Related biology news :
1. J. Craig Venter, Ph.D., Co-Founder and CEO, Human Longevity, Inc. (HLI) Participates in White House Precision Medicine Event
2. Alfred Russel Wallace: Co-founder of the theory of biological evolution
3. Albert Einstein College of Medicine receives grant from the Michael J. Fox Foundation to fund drug discovery project targeting Parkinsons
4. BUSMs Michael F. Holick receives American Society for Bone and Mineral Research award
5. TGen Dr. Michael Barrett awarded $200,000 grant at national cancer conference in San Diego
6. EyeLock Appoints Michael Fiorito Vice President of Enterprise Accounts
7. Anne Glover and Sir Michael Stratton to meet the press at The EMBO Meeting 2013 in Amsterdam
8. Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch
9. MedNet Solutions Named Most Outstanding eClinical Solutions Company
10. ACMG Annual Clinical Genetics Meeting Named One of the Fastest Growing Meetings in USA for Fourth Time
11. MedNet Solutions Named A Finalist For The 16th Annual Tekne Awards